Omnicare Drugs India Private Limited, a active private limited company, was established on 03 April 2017 in Hyderabad, Telangana, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U74999TG2017PTC116303. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹500.00 Cr and a paid-up capital of ₹296.97 Cr.
It upholds a compliant status. Employing 7 professional, Its leadership includes Suresh Kumar Nandiraju (Director), Menachery Paul Ittyrah (Director), Bavaguthu Raghuram Shetty (Nominee Director). Past directors included Suresh Kumar Nandiraju, Binay Raghuram Shetty, Shireesh Shetty. It holds ₹142.80 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2019, with the balance sheet filed on 31 March 2019. It is based at Off No. 401, 4Th Floor, Manjeera Trinity Corporate Jntu-Hitech City Road, Kukatpally, Hyderabad, Telangana, 500072.
U74999TG2017PTC116303
116303
03 April 2017
₹500.00 Cr
₹296.97 Cr
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Omnicare Drugs India Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Suresh Kumar Nandiraju | Director | 03 Apr 2017 | Current |
| Menachery Paul Ittyrah | Director | 03 Apr 2017 | Current |
| Bavaguthu Raghuram Shetty | Nominee Director | 03 Apr 2017 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 08 Aug 2020 | Past |
| Pramod Abcsdd | Additional Director | 31 Dec 2018 | Past |
| Pramod Abcsdd | Additional Director | 20 Oct 2022 | Past |
| Pramod Abcsdd | Additional Director | 31 Dec 2018 | Past |
| Pramod Abcsdd | Cfo(Kmp) | 20 Mar 2020 | Past |
| Pramod Abcsdd | Company Secretary | - | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Omnicare Drugs India Private Limited, for the financial year ended 2019, experienced significant growth in revenue, with a 3165.73% increase. The company also saw a substantial improvement in profitability, with a 566.79% increase in profit. The company's net worth Soared by an impressive increase of 252.57%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2019, Omnicare Drugs India had a promoter holding of 100.00%. The company had 2 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹1,428,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 11 Dec 2018 | Others | ₹142.80 Cr | Open |
Explore comprehensive loan charge details -
Omnicare Drugs India has a workforce of 7 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Omnicare Drugs India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Omnicare Drugs India's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Omnicare Drugs India Private Limited last Annual general meeting of members was held on 30 Sep 2019 as per latest MCA records. was completed.
Progress on A charge with Others of Rs. 142.80 Cr registered on 11 Dec 2018 with Charge ID 100222768 was modified on 23 Jul 2019. was documented.
Progress on Omnicare Drugs India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2019 with Roc Hyderabad. was documented.
The activity A charge with Others amounted to Rs. 142.80 Cr with Charge ID 100222768 was registered on 11 Dec 2018. was completed.
Progress on Suresh Kumar Nandiraju was appointed as a Director was appointed as a Director on 03 Apr 2017 & has been associated with this company since 8 years 7 months . was documented.
Menachery Paul Ittyrah was appointed as a Director was appointed as a Director on 03 Apr 2017 & has been associated with this company since 8 years 7 months . was recorded as a recent event.
The CIN of Omnicare Drugs India Private Limited is U74999TG2017PTC116303.
Omnicare Drugs India Private Limited is headquartered at Off No. 401, 4Th Floor, Manjeera Trinity Corporate Jntu-Hitech City Road, Kukatpally, Hyderabad, Telangana, 500072.
Omnicare Drugs India Private Limited was incorporated on 03 April 2017.
The current directors of Omnicare Drugs India Private Limited are
The primary industry of Omnicare Drugs India Private Limited is Manufacturing.
Omnicare Drugs India Private Limited is unlisted.
The authorized capital of Omnicare Drugs India Private Limited is ₹500.00 Cr, and the paid-up capital is ₹296.97 Cr.
The compliance status of Omnicare Drugs India Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX